Chemicals & Pharmaceuticals

AstraZeneca to shed UK jobs

Pharmaceutical giant AstraZeneca says it plans to close its Charnwood site, Manufacturing Digital can reveal

GSK to build new UK biotech plant

Move will see many new jobs created

GSK profits soar

GlaxoSmithKline reveals a 32 percent jump in fourth-quarter net profit, inflated by contributions from emerging markets

Job losses expected at GlaxoSmithKline

Several UK newspapers are reporting expected job losses at the drugs giant

Novartis to buy eye care product manufacturer Alcon

Novartis to acquire majority control of Alcon, a global leader in eye care, and proposes merger for full ownership

Revenues rise at pharmaceuticals company BTG

Drug group acquisition boosts international specialty pharmaceuticals company BTG, Manufacturing Digital has learnt.

Three of the world's biggest drugmakers posted better-than-expected quarterly earnings on Wednesday and gave bullish forecasts for the rest of the year, demonstrating the industry's resilience in the weak economy.

J&J profit falls but beats forecasts

Johnson & Johnson posted a 5 percent drop in second-quarter earnings on Tuesday, but profit and revenue beat analysts' forecasts thanks to surprisingly resilient pharmaceutical and consumer product sales.

An image courtesy of Johnson & Johnson. REUTERS/Handout

Eisai opens new £100m UK facility

Eisai Co. Ltd has opened a new 100 million pound pharmaceuticals manufacturing and research facility in Hatfield, UK, creating 250 research jobs.

Oils, drugmakers nudge FTSE up

Advancing energy firms pushed the top share index up 0.5 percent by midday on Tuesday as oil prices rebounded, while defensive stocks were also in demand on growing caution over the pace of economic recovery.

The outside of the London Stock Exchange building is seen March 7, 2005. REUTERS/Toby Melville

Pfizer eyes deals to raise emerging markets presence

Pfizer Inc , the world's largest drugmaker, is looking to conclude deals in emerging markets over "few months" to raise its share of a market estimated at about $80 billion, an executive said on Sunday.

The entrance of Pfizer World headquaters in New York City, is seen this file photo from August 31, 2003. REUTERS/Jeff Christensen

Braun closes Carlow plant

German personal-care products company Braun has announced the end of manufacturing in Carlow.

Tate & Lyle says outlook difficult to predict

Sugar and sweetener maker Tate & Lyle said Thursday it was difficult to predict with confidence the outlook for 2010, given the global recession and its uncertain impact on customer demand.

No Unilever return to financial targets

Consumer goods giant Unilever beat forecasts with a 4.8 percent rise in first-quarter underlying sales on Thursday and said it plans to step up innovation and brand support from the second-quarter.

AstraZeneca in U.S. talks over swine flu vaccine

AstraZeneca is in talks with U.S. health authorities about developing a vaccine for swine flu.

Pfizer profit beats forecast

Pfizer Inc reported a better-than-expected first-quarter profit on Tuesday, as cost-cutting helped offset sharply lower sales of its Lipitor cholesterol fighter and its Chantix smoking-cessation drug.

A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. REUTERS/Francois Lenoir

GlaxoSmithKline close to acquiring Stiefel, say reports

GlaxoSmithKline PLC is reportedly nearing a deal to purchase privately held U.S. skincare products maker Stiefel Laboratories for $3 billion.

Sanofi-Aventis to buy BiPar Sciences

French drugmaker, Sanofi-Aventis, is to buy cancer specialist BiPar Sciences for $500 million.

SSL International plc profits up 30%

Condom manufacturer SSL International experiences “trade boom” during the economic crisis.

Dow Chemical sells Morton Salt to K+S

Dow Chemical Co said it will sell Morton Salt to German fertilizer maker K+S Aktiengesellschaft.

Glaxo sells more of Quest stake

GlaxoSmithKline has sold a further chunk of its stake in Quest Diagnostics for $256 million (176.2 million pounds).

Dow, Rohm settle dispute, merger to go through

GEORGETOWN, Del. Dow Chemical Co agreed on Monday to go through with its purchase of Rohm and Haas Co reaching a settlement after the two sides were scheduled to go to a trial over Dow's refusal to close the deal.

Dow Chemical Company Chief Executive Officer Andrew Liveris delivers a speech at the Global Management Forum in Tokyo October 27, 2008. REUTERS/Yuriko Nakao

Dow Chemical says Rohm talks going well

GEORGETOWN, Dow Chemical Co said on Sunday that settlement talks with Rohm and Haas Co were going "quite well" on the eve of a scheduled court hearing on their soured $15 billion merger.

Dow Chemical shares drop to new 24-year-low

Shares of Dow Chemical Co tumbled to a new 24-year low on Thursday ahead of a trial next week to find whether Dow can get out of its more than $15 billion takeover of Rohm and Haas Co .

IPIC to buy Nova Chemicals

CALGARY, Abu Dhabi state-owned International Petroleum Investment Co launched a $500 million takeover of Nova Chemicals Corp on Monday, a friendly deal to rescue the plastics maker from a financial crisis due to its high debt.

Jeffrey Lipton, CEO of Nova Chemicals, answers questions at the companies annual general meeting in Calgary, Alberta, April 12, 2007. REUTERS/Todd Korol

Nova CEO says still able to work with lenders

CALGARY, Nova Chemicals Corp , which faces a number of debt commitments in the coming months, still believes it can strike deals with lenders, the raw plastics maker's chief executive said on Tuesday.

Coins stacked on top of a list of investments

Dow Chemical slashes dividend 64 percent

Dow Chemical Co slashed its quarterly dividend by 64 percent on Thursday as it struggles with plunging demand for chemicals and a dispute over its refusal to close on a takeover of rival Rohm and Haas Co

Rohm and Haas earnings tumble

Chemical maker Rohm and Haas Co , which is locked in a merger dispute with suitor Dow Chemical Co , said on Monday its fourth-quarter profit fell as the global economic slowdown hurt demand for its paints, coatings and electronic materials.

Procter & Gamble looks to exit pharmaceuticals: report

(Reuters) - Procter & Gamble Co is working with Goldman Sachs Group to identify potential buyers for its pharmaceuticals brands or find other ways to exit the business, people close to the matter said late on Wednesday, the Financial Times reported.

Procter & Gamble's corporate headquarters is seen in Cincinnati, Ohio, January 28, 2005. REUTERS/John Sommers II JPSII

Nova shares surge on financing speculation

CALGARY, Nova Chemicals Corp shares surged more than 41 percent on Wednesday on reports, since denied, that the raw plastics maker has secured $100 million to help it meet its financial obligations .

Dow Chemical posts loss on slumping sales

Dow Chemical Co posted a fourth-quarter loss on Tuesday, as sales and volumes fell sharply amid the global economic downturn.

Dow Chemical CEO Andrew Liveris delivers a speech at the Global Management Forum in Tokyo, October 27, 2008. REUTERS/Yuriko Nakao

Dow Chemical posts fourth-quarter loss

Dow Chemical Co posted a fourth-quarter loss on Tuesday, as sales and volumes fell sharply amid the global economic downturn.

Rohm and Haas shares fall on concern over Dow deal

Dow Chemical Co refused to close its $15.3 billion takeover of rival Rohm and Haas Co by Tuesday, breaking a key condition of the merger and sparking speculation that the deal might collapse.

Cars drive past a plant of U.S. chemical producer Dow near the eastern German village of Lippendorf, south of Leipzig, in this March 25, 2004 file photo. REUTERS/Arnd Wiegmann

Rohm and Haas plans to cut 900 jobs

Rohm and Haas Co said on Tuesday it plans to cut 900 jobs, or 5.5 percent of its workforce, in a bid to tackle the slump in demand and widespread market weakness.

Lyondell gets over $2 billion in bankruptcy financing

Lyondell Chemical Co received bankruptcy court approval on Wednesday to access more than $2 billion in interim debtor-in-possession financing and an emergency $100 million loan, saying it had run out of cash.

Dow Chemical prepared to delay Rohm & Haas deal: report

(Reuters) - Dow Chemical Co is prepared to miss next week's deadline to clinch the $15 billion takeover of Rohm & Haas in an effort to raise enough cash to complete the deal without taking on too much debt, the Financial Times reported on its website late on Tuesday.

LyondellBasell U.S. units file for bankruptcy

The U.S. operations of LyondellBasell, the world's third-largest petrochemical company, filed for bankruptcy protection under the weight of a massive debt load and slumping demand for its products.

LyondellBasell considers bankruptcy: WSJ

LyondellBasell Industries AF SCA has told lenders it is considering filing for bankruptcy protection, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

Rohm and Dow shares fall on investor concern over deal

Shares of Dow Chemical and Rohm & Haas plunged by more than 20 percent on Monday, after Kuwait scrapped a $17.4 billion joint venture with Dow, potentially upsetting its plans to buy rival Rohm & Haas.

DIGITAL MAGAZINE

OTHER FEATURES

- Free Subscription
- Read Now
- View Publications
- Back Issues

Associations and Events